NCT06520332

Brief Summary

Periodontal disease , especially in its advanced stages , is one of the main cause for tooth loss .Tooth replacement options include dental implants , fixed partial denture , removable partial denture and complete dentures . Dental implants have become more common treatment for replacing missing teeth and aim to improve chewing efficiency, physical health and esthetic. Although conventional implants cannot be placed in every site due to resorption of the alveolar socket after extraction. Thus short implants can be used as an alternative . Hence, this study aims at comparing the clinical efficacy of short implants with standard length implants placed in native or augmented bone in patients with a history of periodontitis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 25, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

July 25, 2024

Status Verified

July 1, 2024

Enrollment Period

9 months

First QC Date

July 19, 2024

Last Update Submit

July 24, 2024

Conditions

Keywords

Dental implant

Outcome Measures

Primary Outcomes (1)

  • The primary outcome that will be assessed is implant survival rate.

    The primary objective of this randomised controlled clinical trial will be to compare the survival rate of short implants (≤ 6 mm ) and standard-length implants (≥ 10 mm) in patients with a history of periodontitis; through clinical and radiographic analysis.

    6 months

Study Arms (2)

10 Short implants will be placed in the residual vertical bone height of 5 to 8mm .

EXPERIMENTAL

One short dental implant will be placed whose length will be less than or equal to 6mm.

Procedure: Dental Implant Surgery - short implant group (less than or equal to 6mm)

10 Standard implants of length ≥ 10mm will be placed in augmented/native bone .

ACTIVE COMPARATOR

This Conventional Dental implant group will act as control.

Procedure: Dental Implant Surgery - Conventional implant group (greater than or equal to 10mm)

Interventions

A mucoperiosteal flap will be raised in edentulous ridge. A short dental implant (experimental group) will be placed according to the standard protocol. The platform of the implant will be placed 2 to 3 mm below CEJ of adjacent teeth. The surgical wound closure will be coapted with mattress and single interrupted sutures

10 Short implants will be placed in the residual vertical bone height of 5 to 8mm .

A mucoperiosteal flap will be raised in edentulous ridge. A standard length implant ( comparative group) ( ≥10mm) will be placed according to the standard protocol in the augmented/native bone . The platform of the implant will be placed 2 to 3 mm below CEJ of adjacent teeth. The surgical wound closure will be coapted with mattress and single interrupted sutures

10 Standard implants of length ≥ 10mm will be placed in augmented/native bone .

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age group - 18 years and above
  • Presence of \>2 mm keratinised tissue to allow flap management.
  • Systemically healthy patients
  • The residual vertical bone height at the implant sites ranging from 6 to 9 mm for short implant placement ; \> 9 mm for standard implant placement.
  • History of periodontitis

You may not qualify if:

  • Medical conditions contraindicating surgical interventions
  • Uncontrolled diabetes
  • Hemorrhagic disorders
  • Intravenous and oral bisphosphonate therapy.
  • Irradiation in head and neck
  • Pregnant and lactating women
  • Subjects with known bone metabolic disorders (paget's disease , fibrous dysplasia etc.)
  • Known smokers and alcoholics

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Krishnadevaraya college of dental sciences

Bangalore, Karantaka, 562157, India

Location

Related Publications (1)

  • Esposito M, Barausse C, Pistilli R, Sammartino G, Grandi G, Felice P. Short implants versus bone augmentation for placing longer implants in atrophic maxillae: One-year post-loading results of a pilot randomised controlled trial. Eur J Oral Implantol. 2015 Autumn;8(3):257-68.

    PMID: 26355170BACKGROUND

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2024

First Posted

July 25, 2024

Study Start

August 1, 2024

Primary Completion

May 1, 2025

Study Completion

August 1, 2025

Last Updated

July 25, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Individual Participant Data will not be shared with other researchers.

Locations